J Pers Med. 2021 Aug 28;11(9). doi: 10.3390/jpm11090855.
Simple and Reliable Method for Gastric Subepithelial Tumor Localization Using Endoscopic Tattooing before Totally Laparoscopic Resection.
Journal of personalized medicine
Sheng-Fu Wang, Hao-Tsai Cheng, Jun-Te Hsu, Chi-Huan Wu, Chun-Wei Chen, Chun-Jung Lin, Kai-Feng Sung
Affiliations
Affiliations
- Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital, Linkou Medical Center, Taoyuan 333, Taiwan.
- School of Medicine, College of Medicine, Chang-Gung University, Taoyuan 333, Taiwan.
- Department of Gastroenterology and Hepatology, New Taipei Municipal TuCheng Hospital, New Taipei City 236, Taiwan.
- Department of General Surgery, Chang-Gung Memorial Hospital, Linkou Medical Center, Taoyuan 333, Taiwan.
PMID: 34575632
PMCID: PMC8469339 DOI: 10.3390/jpm11090855
Abstract
BACKGROUND: Totally laparoscopic surgery for early gastric cancer and subepithelial tumors has been popularized worldwide, yet localization of early or small-sized tumors is a persistent challenge due to difficulty being identified with the lack of manual tactile sensation. Thus, accurate localization with tattooing before the surgery would help improve efficiency during surgery. There are multiple methods to localize tumors before laparoscopy, each with varying advantages and disadvantages. The use of endoscopic tattooing with dye has been carried out for several decades due to its safety, lower cost, and convenience. However, there is a lack of studies on endoscopic tattooing before totally laparoscopic resection.
AIMS: To evaluate the effect of endoscopic tattooing with dye for gastric subepithelial tumors localization before laparoscopic resection and to evaluate the tattooing effect on different locations of tumors in stomach.
METHOD: We retrospectively collected data of patients with gastric subepithelial tumors who underwent endoscopic tattooing before totally laparoscopic resection from 2017 to 2020 in a university affiliated medical center. All patients were analyzed for preoperative characteristics and then categorized into two groups based on tumor locations concerning the difficulty of laparoscopic surgery. The independent t test and Chi-square test were performed to compare perioperative outcome and complications between these two groups.
RESULT: A total of 19 patients were included retrospectively at our center. The individuals were 5 male and 14 female patients with a mean age of 58.2 years old. Most patients had no symptoms, and the tumors were found incidentally in 12 patients (63%). All tumors were identified clearly during laparoscopic resection. The mean tumor size was 2.3 cm. The surgeries took an average of 111 min and a mean of 7 mL blood loss was found. All tumors had negative resection margins with no recurrence during follow-up. Gastrointestinal stromal tumor was the major pathologic diagnosis, found in 12 patients (63%), followed by the leiomyoma in 5 patients (26%). Only three patients had mild adverse effects after surgery and the symptoms were self-limited. Our analysis found no significant difference in preoperative patient characteristics and perioperative outcomes between patients with differing tumor locations.
CONCLUSION: This study is the first and largest report on endoscopic tattooing with dye before laparoscopic resection of gastric subepithelial tumor resection. Our results emphasize that endoscopic tattooing with dye is a safe and reliable method for localizing subepithelial tumors in the stomach prior to totally laparoscopic resection, with no correlation to where the tumor is located.
Keywords: gastric subepithelial tumor; laparoscopic surgery; tattoo
References
- Adv Ther. 2012 Oct;29(10):864-73 - PubMed
- J Laparoendosc Adv Surg Tech A. 2018 Aug;28(8):962-966 - PubMed
- Mol Clin Oncol. 2017 Apr;6(4):483-486 - PubMed
- Zhonghua Zhong Liu Za Zhi. 1989 Mar;11(2):136-8 - PubMed
- Asian J Surg. 2017 Sep;40(5):407-414 - PubMed
- World J Gastrointest Endosc. 2015 Sep 10;7(12):1062-9 - PubMed
- J Gastric Cancer. 2021 Mar;21(1):4-15 - PubMed
- Surg Endosc. 1999 Apr;13(4):397-400 - PubMed
- Dig Endosc. 2017 May;29(4):431-443 - PubMed
- Surg Endosc. 2014 Sep;28(9):2752-9 - PubMed
- Surg Endosc. 2018 Mar;32(3):1304-1313 - PubMed
- Surg Endosc. 2007 May;21(5):810-5 - PubMed
- Gastrointest Endosc. 2010 Oct;72(4):681-5 - PubMed
- Surg Endosc. 2008 Feb;22(2):501-5 - PubMed
- Surg Endosc. 2011 Jul;25(7):2372-7 - PubMed
- Surg Endosc. 2011 Jan;25(1):271-7 - PubMed
- J Gastric Cancer. 2017 Sep;17(3):220-227 - PubMed
- J Korean Surg Soc. 2013 Feb;84(2):80-7 - PubMed
- Gastrointest Endosc. 1991 Jan-Feb;37(1):56-8 - PubMed
- Endosc Int Open. 2019 Nov;7(11):E1327-E1332 - PubMed
- Surg Endosc. 1999 Jan;13(1):71-4 - PubMed
- Gastrointest Endosc. 2017 Jun;85(6):1117-1132 - PubMed
- Pancreatology. 2021 Mar;21(2):443-450 - PubMed
- Gut Liver. 2011 Dec;5(4):418-26 - PubMed
- Endoscopy. 2014 Jan;46(1):39-45 - PubMed
- J Gastroenterol Hepatol. 2013 Feb;28(2):262-7 - PubMed
- Gastric Cancer. 2011 Jun;14(2):97-100 - PubMed
- Surg Endosc. 1989;3(3):142-7 - PubMed
- Surg Endosc. 2009 May;23(5):1146-9 - PubMed
- World J Gastroenterol. 2014 Sep 28;20(36):13035-43 - PubMed
- Ann Oncol. 2005 Apr;16(4):566-78 - PubMed
- Scand J Gastroenterol. 2016;51(4):486-93 - PubMed
- World J Gastrointest Endosc. 2011 Dec 16;3(12):256-60 - PubMed
- Gastrointest Endosc. 2020 Jul;92(1):108-119.e3 - PubMed
- Gastroenterology. 2021 Sep;161(3):899-909.e5 - PubMed
- Surg Endosc. 2009 Feb;23(2):347-51 - PubMed
- Surgery. 2006 Apr;139(4):484-92 - PubMed
- Gastrointest Endosc. 2002 Sep;56(3):339-42 - PubMed
Publication Types